Titre : Glycérophosphate

Glycérophosphate : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une carence en glycérophosphate ?

Un diagnostic se fait par des tests sanguins mesurant les niveaux de phosphates.
Carence en phosphates Tests sanguins
#2

Quels tests sont utilisés pour évaluer les glycérophosphates ?

Les tests biochimiques et les analyses de sang sont couramment utilisés.
Analyses biochimiques Tests sanguins
#3

Quels symptômes indiquent un déséquilibre en glycérophosphate ?

Fatigue, faiblesse musculaire et troubles neurologiques peuvent indiquer un déséquilibre.
Fatigue Troubles neurologiques
#4

Les niveaux de glycérophosphate peuvent-ils être mesurés ?

Oui, les niveaux peuvent être mesurés par des tests spécifiques en laboratoire.
Tests de laboratoire Mesure des phosphates
#5

Quel rôle joue l'historique médical dans le diagnostic ?

L'historique médical aide à identifier les facteurs de risque et les symptômes associés.
Historique médical Facteurs de risque

Symptômes 5

#1

Quels sont les symptômes d'une surconsommation de glycérophosphate ?

Des symptômes comme des douleurs abdominales et des nausées peuvent apparaître.
Douleurs abdominales Nausées
#2

Comment reconnaître une carence en glycérophosphate ?

Les signes incluent fatigue, troubles de la mémoire et faiblesse musculaire.
Fatigue Troubles de la mémoire
#3

Les troubles neurologiques sont-ils liés aux glycérophosphates ?

Oui, un déséquilibre peut entraîner des troubles neurologiques variés.
Troubles neurologiques Déséquilibre métabolique
#4

Y a-t-il des symptômes cutanés associés aux glycérophosphates ?

Des éruptions cutanées peuvent survenir en cas d'allergie ou d'intolérance.
Éruptions cutanées Allergies
#5

Les troubles digestifs peuvent-ils être causés par des glycérophosphates ?

Oui, des troubles digestifs comme des ballonnements peuvent se manifester.
Troubles digestifs Ballonnements

Prévention 5

#1

Comment prévenir une carence en glycérophosphate ?

Une alimentation équilibrée et riche en phosphates est essentielle pour la prévention.
Prévention Alimentation équilibrée
#2

Quels aliments sont riches en glycérophosphate ?

Les produits laitiers, les viandes et les noix sont de bonnes sources de phosphates.
Produits laitiers Sources alimentaires
#3

L'hydratation joue-t-elle un rôle dans la prévention ?

Oui, une bonne hydratation aide à maintenir l'équilibre des électrolytes, y compris les phosphates.
Hydratation Équilibre électrolytique
#4

Les exercices physiques peuvent-ils aider à prévenir des déséquilibres ?

Oui, l'exercice régulier contribue à un métabolisme sain et à l'équilibre des nutriments.
Exercice physique Métabolisme
#5

Faut-il surveiller les niveaux de glycérophosphate régulièrement ?

Oui, un suivi régulier peut aider à détecter des déséquilibres précocement.
Suivi médical Déséquilibres

Traitements 5

#1

Quels traitements existent pour une carence en glycérophosphate ?

Des suppléments de phosphates et des modifications alimentaires sont recommandés.
Suppléments de phosphates Modifications alimentaires
#2

Comment traiter une surconsommation de glycérophosphate ?

Réduire l'apport alimentaire et consulter un professionnel de santé est conseillé.
Surconsommation Consultation médicale
#3

Les médicaments peuvent-ils affecter les niveaux de glycérophosphate ?

Oui, certains médicaments peuvent influencer les niveaux de phosphates dans le corps.
Médicaments Niveaux de phosphates
#4

Y a-t-il des traitements naturels pour équilibrer les glycérophosphates ?

Une alimentation riche en fruits et légumes peut aider à équilibrer les niveaux.
Alimentation Fruits et légumes
#5

Les thérapies alternatives sont-elles efficaces pour les glycérophosphates ?

Certaines thérapies alternatives peuvent aider, mais des preuves scientifiques manquent.
Thérapies alternatives Efficacité

Complications 5

#1

Quelles complications peuvent survenir avec une carence en glycérophosphate ?

Des complications comme des troubles osseux et neurologiques peuvent se développer.
Complications Troubles osseux
#2

Une surconsommation de glycérophosphate peut-elle être dangereuse ?

Oui, elle peut entraîner des problèmes rénaux et des déséquilibres électrolytiques.
Surconsommation Problèmes rénaux
#3

Les complications sont-elles réversibles ?

Certaines complications peuvent être réversibles avec un traitement approprié.
Complications réversibles Traitement
#4

Quels sont les risques à long terme d'un déséquilibre en glycérophosphate ?

Des risques à long terme incluent des maladies osseuses et des troubles cognitifs.
Risques à long terme Maladies osseuses
#5

Les complications peuvent-elles affecter la qualité de vie ?

Oui, des complications peuvent significativement impacter la qualité de vie quotidienne.
Qualité de vie Impact des complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque d'une carence en glycérophosphate ?

Les régimes alimentaires déséquilibrés et certaines maladies augmentent le risque.
Facteurs de risque Régimes alimentaires
#2

L'âge influence-t-il les niveaux de glycérophosphate ?

Oui, les personnes âgées sont plus susceptibles de développer des carences.
Âge Carences nutritionnelles
#3

Les maladies rénales sont-elles un facteur de risque ?

Oui, les maladies rénales peuvent affecter l'excrétion des phosphates et causer des déséquilibres.
Maladies rénales Déséquilibres électrolytiques
#4

Le stress peut-il affecter les niveaux de glycérophosphate ?

Oui, le stress chronique peut perturber le métabolisme et les niveaux de phosphates.
Stress Métabolisme
#5

Les habitudes alimentaires influencent-elles les niveaux de glycérophosphate ?

Oui, une alimentation pauvre en phosphates augmente le risque de carence.
Habitudes alimentaires Carence en phosphates
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Glycérophosphate : Questions médicales les plus fréquentes", "headline": "Glycérophosphate : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Glycérophosphate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-13", "dateModified": "2026-03-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Glycérophosphate" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phospholipides", "url": "https://questionsmedicales.fr/mesh/D010743", "about": { "@type": "MedicalCondition", "name": "Phospholipides", "code": { "@type": "MedicalCode", "code": "D010743", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acides phosphatidiques", "alternateName": "Phosphatidic Acids", "url": "https://questionsmedicales.fr/mesh/D010712", "about": { "@type": "MedicalCondition", "name": "Acides phosphatidiques", "code": { "@type": "MedicalCode", "code": "D010712", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycérophospholipides", "alternateName": "Glycerophospholipids", "url": "https://questionsmedicales.fr/mesh/D020404", "about": { "@type": "MedicalCondition", "name": "Glycérophospholipides", "code": { "@type": "MedicalCode", "code": "D020404", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Phosphatidylcholines", "alternateName": "Phosphatidylcholines", "url": "https://questionsmedicales.fr/mesh/D010713", "about": { "@type": "MedicalCondition", "name": "Phosphatidylcholines", "code": { "@type": "MedicalCode", "code": "D010713", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dimyristoylphosphatidylcholine", "alternateName": "Dimyristoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D004134", "about": { "@type": "MedicalCondition", "name": "Dimyristoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D004134", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.200" } } }, { "@type": "MedicalWebPage", "name": "1,2-Dipalmitoylphosphatidylcholine", "alternateName": "1,2-Dipalmitoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D015060", "about": { "@type": "MedicalCondition", "name": "1,2-Dipalmitoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D015060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.224" } } }, { "@type": "MedicalWebPage", "name": "Glycerylphosphorylcholine", "alternateName": "Glycerylphosphorylcholine", "url": "https://questionsmedicales.fr/mesh/D005997", "about": { "@type": "MedicalCondition", "name": "Glycerylphosphorylcholine", "code": { "@type": "MedicalCode", "code": "D005997", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.806.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Dimyristoylphosphatidylcholine", "alternateName": "Dimyristoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D004134", "about": { "@type": "MedicalCondition", "name": "Dimyristoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D004134", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.200" } } }, { "@type": "MedicalWebPage", "name": "1,2-Dipalmitoylphosphatidylcholine", "alternateName": "1,2-Dipalmitoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D015060", "about": { "@type": "MedicalCondition", "name": "1,2-Dipalmitoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D015060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.224" } } }, { "@type": "MedicalWebPage", "name": "Glycerylphosphorylcholine", "alternateName": "Glycerylphosphorylcholine", "url": "https://questionsmedicales.fr/mesh/D005997", "about": { "@type": "MedicalCondition", "name": "Glycerylphosphorylcholine", "code": { "@type": "MedicalCode", "code": "D005997", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.806.500" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidyléthanolamine", "alternateName": "Phosphatidylethanolamines", "url": "https://questionsmedicales.fr/mesh/D010714", "about": { "@type": "MedicalCondition", "name": "Phosphatidyléthanolamine", "code": { "@type": "MedicalCode", "code": "D010714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.840" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidylglycérol", "alternateName": "Phosphatidylglycerols", "url": "https://questionsmedicales.fr/mesh/D010715", "about": { "@type": "MedicalCondition", "name": "Phosphatidylglycérol", "code": { "@type": "MedicalCode", "code": "D010715", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.885" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidyl inositols", "alternateName": "Phosphatidylinositols", "url": "https://questionsmedicales.fr/mesh/D010716", "about": { "@type": "MedicalCondition", "name": "Phosphatidyl inositols", "code": { "@type": "MedicalCode", "code": "D010716", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosylphosphatidylinositols", "alternateName": "Glycosylphosphatidylinositols", "url": "https://questionsmedicales.fr/mesh/D017261", "about": { "@type": "MedicalCondition", "name": "Glycosylphosphatidylinositols", "code": { "@type": "MedicalCode", "code": "D017261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.250" } } }, { "@type": "MedicalWebPage", "name": "Phosphates phosphatidylinositol", "alternateName": "Phosphatidylinositol Phosphates", "url": "https://questionsmedicales.fr/mesh/D018129", "about": { "@type": "MedicalCondition", "name": "Phosphates phosphatidylinositol", "code": { "@type": "MedicalCode", "code": "D018129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Glycosylphosphatidylinositols", "alternateName": "Glycosylphosphatidylinositols", "url": "https://questionsmedicales.fr/mesh/D017261", "about": { "@type": "MedicalCondition", "name": "Glycosylphosphatidylinositols", "code": { "@type": "MedicalCode", "code": "D017261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.250" } } }, { "@type": "MedicalWebPage", "name": "Phosphates phosphatidylinositol", "alternateName": "Phosphatidylinositol Phosphates", "url": "https://questionsmedicales.fr/mesh/D018129", "about": { "@type": "MedicalCondition", "name": "Phosphates phosphatidylinositol", "code": { "@type": "MedicalCode", "code": "D018129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidylsérine", "alternateName": "Phosphatidylserines", "url": "https://questionsmedicales.fr/mesh/D010718", "about": { "@type": "MedicalCondition", "name": "Phosphatidylsérine", "code": { "@type": "MedicalCode", "code": "D010718", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.971" } } }, { "@type": "MedicalWebPage", "name": "Éther-phospholipides", "alternateName": "Phospholipid Ethers", "url": "https://questionsmedicales.fr/mesh/D010742", "about": { "@type": "MedicalCondition", "name": "Éther-phospholipides", "code": { "@type": "MedicalCode", "code": "D010742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.985" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acétalphosphatides", "alternateName": "Plasmalogens", "url": "https://questionsmedicales.fr/mesh/D010955", "about": { "@type": "MedicalCondition", "name": "Acétalphosphatides", "code": { "@type": "MedicalCode", "code": "D010955", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.985.820" } } } ] }, { "@type": "MedicalWebPage", "name": "Acétalphosphatides", "alternateName": "Plasmalogens", "url": "https://questionsmedicales.fr/mesh/D010955", "about": { "@type": "MedicalCondition", "name": "Acétalphosphatides", "code": { "@type": "MedicalCode", "code": "D010955", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.985.820" } } } ] }, { "@type": "MedicalWebPage", "name": "Phosphatidylcholines", "alternateName": "Phosphatidylcholines", "url": "https://questionsmedicales.fr/mesh/D010713", "about": { "@type": "MedicalCondition", "name": "Phosphatidylcholines", "code": { "@type": "MedicalCode", "code": "D010713", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dimyristoylphosphatidylcholine", "alternateName": "Dimyristoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D004134", "about": { "@type": "MedicalCondition", "name": "Dimyristoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D004134", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.200" } } }, { "@type": "MedicalWebPage", "name": "1,2-Dipalmitoylphosphatidylcholine", "alternateName": "1,2-Dipalmitoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D015060", "about": { "@type": "MedicalCondition", "name": "1,2-Dipalmitoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D015060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.224" } } }, { "@type": "MedicalWebPage", "name": "Glycerylphosphorylcholine", "alternateName": "Glycerylphosphorylcholine", "url": "https://questionsmedicales.fr/mesh/D005997", "about": { "@type": "MedicalCondition", "name": "Glycerylphosphorylcholine", "code": { "@type": "MedicalCode", "code": "D005997", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.806.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Dimyristoylphosphatidylcholine", "alternateName": "Dimyristoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D004134", "about": { "@type": "MedicalCondition", "name": "Dimyristoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D004134", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.200" } } }, { "@type": "MedicalWebPage", "name": "1,2-Dipalmitoylphosphatidylcholine", "alternateName": "1,2-Dipalmitoylphosphatidylcholine", "url": "https://questionsmedicales.fr/mesh/D015060", "about": { "@type": "MedicalCondition", "name": "1,2-Dipalmitoylphosphatidylcholine", "code": { "@type": "MedicalCode", "code": "D015060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.224" } } }, { "@type": "MedicalWebPage", "name": "Glycerylphosphorylcholine", "alternateName": "Glycerylphosphorylcholine", "url": "https://questionsmedicales.fr/mesh/D005997", "about": { "@type": "MedicalCondition", "name": "Glycerylphosphorylcholine", "code": { "@type": "MedicalCode", "code": "D005997", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.800.806.500" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidyléthanolamine", "alternateName": "Phosphatidylethanolamines", "url": "https://questionsmedicales.fr/mesh/D010714", "about": { "@type": "MedicalCondition", "name": "Phosphatidyléthanolamine", "code": { "@type": "MedicalCode", "code": "D010714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.840" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidylglycérol", "alternateName": "Phosphatidylglycerols", "url": "https://questionsmedicales.fr/mesh/D010715", "about": { "@type": "MedicalCondition", "name": "Phosphatidylglycérol", "code": { "@type": "MedicalCode", "code": "D010715", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.885" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidyl inositols", "alternateName": "Phosphatidylinositols", "url": "https://questionsmedicales.fr/mesh/D010716", "about": { "@type": "MedicalCondition", "name": "Phosphatidyl inositols", "code": { "@type": "MedicalCode", "code": "D010716", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosylphosphatidylinositols", "alternateName": "Glycosylphosphatidylinositols", "url": "https://questionsmedicales.fr/mesh/D017261", "about": { "@type": "MedicalCondition", "name": "Glycosylphosphatidylinositols", "code": { "@type": "MedicalCode", "code": "D017261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.250" } } }, { "@type": "MedicalWebPage", "name": "Phosphates phosphatidylinositol", "alternateName": "Phosphatidylinositol Phosphates", "url": "https://questionsmedicales.fr/mesh/D018129", "about": { "@type": "MedicalCondition", "name": "Phosphates phosphatidylinositol", "code": { "@type": "MedicalCode", "code": "D018129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Glycosylphosphatidylinositols", "alternateName": "Glycosylphosphatidylinositols", "url": "https://questionsmedicales.fr/mesh/D017261", "about": { "@type": "MedicalCondition", "name": "Glycosylphosphatidylinositols", "code": { "@type": "MedicalCode", "code": "D017261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.250" } } }, { "@type": "MedicalWebPage", "name": "Phosphates phosphatidylinositol", "alternateName": "Phosphatidylinositol Phosphates", "url": "https://questionsmedicales.fr/mesh/D018129", "about": { "@type": "MedicalCondition", "name": "Phosphates phosphatidylinositol", "code": { "@type": "MedicalCode", "code": "D018129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Phosphatidylinositol diphosphate-4,5", "alternateName": "Phosphatidylinositol 4,5-Diphosphate", "url": "https://questionsmedicales.fr/mesh/D019269", "about": { "@type": "MedicalCondition", "name": "Phosphatidylinositol diphosphate-4,5", "code": { "@type": "MedicalCode", "code": "D019269", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.942.625.900" } } }, { "@type": "MedicalWebPage", "name": "Phosphatidylsérine", "alternateName": "Phosphatidylserines", "url": "https://questionsmedicales.fr/mesh/D010718", "about": { "@type": "MedicalCondition", "name": "Phosphatidylsérine", "code": { "@type": "MedicalCode", "code": "D010718", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.971" } } }, { "@type": "MedicalWebPage", "name": "Éther-phospholipides", "alternateName": "Phospholipid Ethers", "url": "https://questionsmedicales.fr/mesh/D010742", "about": { "@type": "MedicalCondition", "name": "Éther-phospholipides", "code": { "@type": "MedicalCode", "code": "D010742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.985" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acétalphosphatides", "alternateName": "Plasmalogens", "url": "https://questionsmedicales.fr/mesh/D010955", "about": { "@type": "MedicalCondition", "name": "Acétalphosphatides", "code": { "@type": "MedicalCode", "code": "D010955", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.985.820" } } } ] }, { "@type": "MedicalWebPage", "name": "Acétalphosphatides", "alternateName": "Plasmalogens", "url": "https://questionsmedicales.fr/mesh/D010955", "about": { "@type": "MedicalCondition", "name": "Acétalphosphatides", "code": { "@type": "MedicalCode", "code": "D010955", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.400.985.820" } } }, { "@type": "MedicalWebPage", "name": "Lysophospholipides", "alternateName": "Lysophospholipids", "url": "https://questionsmedicales.fr/mesh/D008246", "about": { "@type": "MedicalCondition", "name": "Lysophospholipides", "code": { "@type": "MedicalCode", "code": "D008246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lysolécithine", "alternateName": "Lysophosphatidylcholines", "url": "https://questionsmedicales.fr/mesh/D008244", "about": { "@type": "MedicalCondition", "name": "Lysolécithine", "code": { "@type": "MedicalCode", "code": "D008244", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.550.550" } } } ] }, { "@type": "MedicalWebPage", "name": "Lysolécithine", "alternateName": "Lysophosphatidylcholines", "url": "https://questionsmedicales.fr/mesh/D008244", "about": { "@type": "MedicalCondition", "name": "Lysolécithine", "code": { "@type": "MedicalCode", "code": "D008244", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.755.375.760.550.550" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Glycérophosphate", "alternateName": "Glycerophosphates", "code": { "@type": "MedicalCode", "code": "D005994", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alberto Carlos Botazzo Delbem", "url": "https://questionsmedicales.fr/author/Alberto%20Carlos%20Botazzo%20Delbem", "affiliation": { "@type": "Organization", "name": "Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil." } }, { "@type": "Person", "name": "Marcelle Danelon", "url": "https://questionsmedicales.fr/author/Marcelle%20Danelon", "affiliation": { "@type": "Organization", "name": "Universidade de Ribeirão Preto (UNAERP), Faculdade de Odontologia, Ribeirão Preto, SP, Brasil." } }, { "@type": "Person", "name": "Emerson Rodrigues de Camargo", "url": "https://questionsmedicales.fr/author/Emerson%20Rodrigues%20de%20Camargo", "affiliation": { "@type": "Organization", "name": "4Federal University of São Carlos, São Carlos, São Paulo Brazil." } }, { "@type": "Person", "name": "Thayse Yumi Hosida", "url": "https://questionsmedicales.fr/author/Thayse%20Yumi%20Hosida", "affiliation": { "@type": "Organization", "name": "Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil." } }, { "@type": "Person", "name": "Douglas Roberto Monteiro", "url": "https://questionsmedicales.fr/author/Douglas%20Roberto%20Monteiro", "affiliation": { "@type": "Organization", "name": "Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Differing responses of osteogenic cell lines to β-glycerophosphate.", "datePublished": "2023-09-02", "url": "https://questionsmedicales.fr/article/37660110", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-40835-w" } }, { "@type": "ScholarlyArticle", "name": "Nitrogen-containing bisphosphonate induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells.", "datePublished": "2024-09-17", "url": "https://questionsmedicales.fr/article/39289624", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12872-024-04048-x" } }, { "@type": "ScholarlyArticle", "name": "Chiral Sodium Glycerophosphate Catalyst for Enantioselective Michael Reactions of Chalcones.", "datePublished": "2024-10-08", "url": "https://questionsmedicales.fr/article/39407691", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules29194763" } }, { "@type": "ScholarlyArticle", "name": "Investigating the Role of β-Disodium Glycerophosphate and Urea in Promoting Growth of", "datePublished": "2024-03-26", "url": "https://questionsmedicales.fr/article/38611312", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/foods13071006" } }, { "@type": "ScholarlyArticle", "name": "Glycerol 3-Phosphate Dehydrogenase: Role of the Protein Conformational Change in Activation of a Readily Reversible Enzyme-Catalyzed Hydride Transfer Reaction.", "datePublished": "2024-03-28", "url": "https://questionsmedicales.fr/article/38546289", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.biochem.3c00702" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Lipides membranaires", "item": "https://questionsmedicales.fr/mesh/D008563" }, { "@type": "ListItem", "position": 4, "name": "Phospholipides", "item": "https://questionsmedicales.fr/mesh/D010743" }, { "@type": "ListItem", "position": 5, "name": "Glycérophosphate", "item": "https://questionsmedicales.fr/mesh/D005994" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Glycérophosphate - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Glycérophosphate", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Glycérophosphate", "description": "Comment diagnostiquer une carence en glycérophosphate ?\nQuels tests sont utilisés pour évaluer les glycérophosphates ?\nQuels symptômes indiquent un déséquilibre en glycérophosphate ?\nLes niveaux de glycérophosphate peuvent-ils être mesurés ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D005994#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Glycérophosphate", "description": "Quels sont les symptômes d'une surconsommation de glycérophosphate ?\nComment reconnaître une carence en glycérophosphate ?\nLes troubles neurologiques sont-ils liés aux glycérophosphates ?\nY a-t-il des symptômes cutanés associés aux glycérophosphates ?\nLes troubles digestifs peuvent-ils être causés par des glycérophosphates ?", "url": "https://questionsmedicales.fr/mesh/D005994#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Glycérophosphate", "description": "Comment prévenir une carence en glycérophosphate ?\nQuels aliments sont riches en glycérophosphate ?\nL'hydratation joue-t-elle un rôle dans la prévention ?\nLes exercices physiques peuvent-ils aider à prévenir des déséquilibres ?\nFaut-il surveiller les niveaux de glycérophosphate régulièrement ?", "url": "https://questionsmedicales.fr/mesh/D005994#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Glycérophosphate", "description": "Quels traitements existent pour une carence en glycérophosphate ?\nComment traiter une surconsommation de glycérophosphate ?\nLes médicaments peuvent-ils affecter les niveaux de glycérophosphate ?\nY a-t-il des traitements naturels pour équilibrer les glycérophosphates ?\nLes thérapies alternatives sont-elles efficaces pour les glycérophosphates ?", "url": "https://questionsmedicales.fr/mesh/D005994#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Glycérophosphate", "description": "Quelles complications peuvent survenir avec une carence en glycérophosphate ?\nUne surconsommation de glycérophosphate peut-elle être dangereuse ?\nLes complications sont-elles réversibles ?\nQuels sont les risques à long terme d'un déséquilibre en glycérophosphate ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D005994#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Glycérophosphate", "description": "Quels sont les facteurs de risque d'une carence en glycérophosphate ?\nL'âge influence-t-il les niveaux de glycérophosphate ?\nLes maladies rénales sont-elles un facteur de risque ?\nLe stress peut-il affecter les niveaux de glycérophosphate ?\nLes habitudes alimentaires influencent-elles les niveaux de glycérophosphate ?", "url": "https://questionsmedicales.fr/mesh/D005994#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en glycérophosphate ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins mesurant les niveaux de phosphates." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les glycérophosphates ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests biochimiques et les analyses de sang sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déséquilibre en glycérophosphate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, faiblesse musculaire et troubles neurologiques peuvent indiquer un déséquilibre." } }, { "@type": "Question", "name": "Les niveaux de glycérophosphate peuvent-ils être mesurés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux peuvent être mesurés par des tests spécifiques en laboratoire." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les facteurs de risque et les symptômes associés." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une surconsommation de glycérophosphate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs abdominales et des nausées peuvent apparaître." } }, { "@type": "Question", "name": "Comment reconnaître une carence en glycérophosphate ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fatigue, troubles de la mémoire et faiblesse musculaire." } }, { "@type": "Question", "name": "Les troubles neurologiques sont-ils liés aux glycérophosphates ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un déséquilibre peut entraîner des troubles neurologiques variés." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés aux glycérophosphates ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en cas d'allergie ou d'intolérance." } }, { "@type": "Question", "name": "Les troubles digestifs peuvent-ils être causés par des glycérophosphates ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles digestifs comme des ballonnements peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir une carence en glycérophosphate ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et riche en phosphates est essentielle pour la prévention." } }, { "@type": "Question", "name": "Quels aliments sont riches en glycérophosphate ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les produits laitiers, les viandes et les noix sont de bonnes sources de phosphates." } }, { "@type": "Question", "name": "L'hydratation joue-t-elle un rôle dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à maintenir l'équilibre des électrolytes, y compris les phosphates." } }, { "@type": "Question", "name": "Les exercices physiques peuvent-ils aider à prévenir des déséquilibres ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier contribue à un métabolisme sain et à l'équilibre des nutriments." } }, { "@type": "Question", "name": "Faut-il surveiller les niveaux de glycérophosphate régulièrement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier peut aider à détecter des déséquilibres précocement." } }, { "@type": "Question", "name": "Quels traitements existent pour une carence en glycérophosphate ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de phosphates et des modifications alimentaires sont recommandés." } }, { "@type": "Question", "name": "Comment traiter une surconsommation de glycérophosphate ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Réduire l'apport alimentaire et consulter un professionnel de santé est conseillé." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils affecter les niveaux de glycérophosphate ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent influencer les niveaux de phosphates dans le corps." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour équilibrer les glycérophosphates ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits et légumes peut aider à équilibrer les niveaux." } }, { "@type": "Question", "name": "Les thérapies alternatives sont-elles efficaces pour les glycérophosphates ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies alternatives peuvent aider, mais des preuves scientifiques manquent." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une carence en glycérophosphate ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles osseux et neurologiques peuvent se développer." } }, { "@type": "Question", "name": "Une surconsommation de glycérophosphate peut-elle être dangereuse ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des problèmes rénaux et des déséquilibres électrolytiques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Quels sont les risques à long terme d'un déséquilibre en glycérophosphate ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des risques à long terme incluent des maladies osseuses et des troubles cognitifs." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications peuvent significativement impacter la qualité de vie quotidienne." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'une carence en glycérophosphate ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les régimes alimentaires déséquilibrés et certaines maladies augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux de glycérophosphate ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des carences." } }, { "@type": "Question", "name": "Les maladies rénales sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies rénales peuvent affecter l'excrétion des phosphates et causer des déséquilibres." } }, { "@type": "Question", "name": "Le stress peut-il affecter les niveaux de glycérophosphate ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber le métabolisme et les niveaux de phosphates." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les niveaux de glycérophosphate ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en phosphates augmente le risque de carence." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 03/03/2026

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

17 au total
└─

Acides phosphatidiques

Phosphatidic Acids D010712 - D10.570.755.375.760
└─└─

Glycérophospholipides

Glycerophospholipids D020404 - D10.570.755.375.760.400
└─└─

Lysophospholipides

Lysophospholipids D008246 - D10.570.755.375.760.550
└─└─└─

Phosphatidylcholines

Phosphatidylcholines D010713 - D10.570.755.375.760.400.800
└─└─└─

Phosphatidyléthanolamine

Phosphatidylethanolamines D010714 - D10.570.755.375.760.400.840
└─└─└─

Phosphatidylglycérol

Phosphatidylglycerols D010715 - D10.570.755.375.760.400.885
└─└─└─

Phosphatidyl inositols

Phosphatidylinositols D010716 - D10.570.755.375.760.400.942
└─└─└─

Phosphatidylsérine

Phosphatidylserines D010718 - D10.570.755.375.760.400.971
└─└─└─

Éther-phospholipides

Phospholipid Ethers D010742 - D10.570.755.375.760.400.985
└─└─└─

Lysolécithine

Lysophosphatidylcholines D008244 - D10.570.755.375.760.550.550
└─└─└─└─

Dimyristoylphosphatidylcholine

Dimyristoylphosphatidylcholine D004134 - D10.570.755.375.760.400.800.200
└─└─└─└─

1,2-Dipalmitoylphosphatidylcholine

1,2-Dipalmitoylphosphatidylcholine D015060 - D10.570.755.375.760.400.800.224
└─└─└─└─

Glycosylphosphatidylinositols

Glycosylphosphatidylinositols D017261 - D10.570.755.375.760.400.942.250
└─└─└─└─

Phosphates phosphatidylinositol

Phosphatidylinositol Phosphates D018129 - D10.570.755.375.760.400.942.625
└─└─└─└─

Acétalphosphatides

Plasmalogens D010955 - D10.570.755.375.760.400.985.820
└─└─└─└─└─

Glycerylphosphorylcholine

Glycerylphosphorylcholine D005997 - D10.570.755.375.760.400.800.806.500
└─└─└─└─└─

Phosphatidylinositol diphosphate-4,5

Phosphatidylinositol 4,5-Diphosphate D019269 - D10.570.755.375.760.400.942.625.900

Auteurs principaux

Thayse Yumi Hosida

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil.

Douglas Roberto Monteiro

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil.
  • Postgraduate Program in Health Sciences, University of Western São Paulo (UNOESTE), Rua José Bongiovani, 700-Cidade Universitária, Presidente Prudente 19050-920, SP, Brazil.

Juliano Pelim Pessan

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil.

Francyenne Maira Castro Gonçalves

3 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio 1193, Araçatuba, SP, Cep 16015-050, Brazil.

Thamires Priscila Cavazana

2 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil.

Caio Sampaio

2 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil.

Leonardo Antônio de Morais

2 publications dans cette catégorie

Affiliations :
  • Department of Preventive and Restorative Dentistry, School of Dentistry, São Paulo State University (UNESP), Rua José Bonifácio, 1193, Araçatuba 16015-050, SP, Brazil.

Jakob Voelkl

2 publications dans cette catégorie

Affiliations :
  • Institute for Physiology, Johannes Kepler University, Linz, Austria.
  • DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
  • Department of Nephrology and Medical Intensive Care, Charité University Medicine, Berlin, Germany.
  • Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany.
Publications dans "Glycérophosphate" :

Burkert Pieske

2 publications dans cette catégorie

Affiliations :
  • DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
  • Berlin Institute of Health (BIH), Berlin, and Department of Internal Medicine and Cardiology, German Heart Center Berlin (DHZB), Berlin, Germany.
  • Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany.
Publications dans "Glycérophosphate" :

Florian Lang

2 publications dans cette catégorie

Affiliations :
  • Department of Vegetative and Clinical Physiology, Eberhard Karl University Tuebingen, Tuebingen, Germany. florian.lang@uni-tuebingen.de.
Publications dans "Glycérophosphate" :

Melanie Schumacher

2 publications dans cette catégorie

Affiliations :
  • Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland.

Pamela Nicholson

2 publications dans cette catégorie

Affiliations :
  • Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland.

Michael H Stoffel

2 publications dans cette catégorie

Affiliations :
  • Division of Veterinary Anatomy, University of Bern, Bern, Switzerland.

Suchismita Chandran

2 publications dans cette catégorie

Affiliations :
  • J. Craig Venter Institute, Rockville, MD, United States.

Adonis D'Mello

2 publications dans cette catégorie

Affiliations :
  • Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, United States.

Li Ma

2 publications dans cette catégorie

Affiliations :
  • J. Craig Venter Institute, Rockville, MD, United States.

Sanjay Vashee

2 publications dans cette catégorie

Affiliations :
  • J. Craig Venter Institute, Rockville, MD, United States.

Sources (22 au total)

Nitrogen-containing bisphosphonate induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells.

Nitrogen-containing bisphosphonate(N-BP)had been found to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells (VSMCs), but the mechanism is not clear. We intend to... β-glycerophosphate (β-GP) was used to induce the osteogenic differentiation and calcification in VSMCs. VSMCs were treated with N-BP or pretreated with downstream products of farnesyl pyrophosphate sy... β-GP induced the osteogenic differentiation and calcification in VSMCs, increased RANKL protein expression and had no significant effect on OPG protein expression. With the treatment of N-BP, the expr... N-BP increases OPG expression and decreases RANKL expression via inhibition of FPPS to inhibit the osteogenic differentiation and calcification in VSMCs....

Glycerol 3-Phosphate Dehydrogenase: Role of the Protein Conformational Change in Activation of a Readily Reversible Enzyme-Catalyzed Hydride Transfer Reaction.

Kinetic parameters are reported for glycerol 3-phosphate dehydrogenase (GPDH)-catalyzed hydride transfer from the whole substrate glycerol 3-phosphate (G3P) or truncated substrate ethylene glycol (EtG...

Enhanced Anti-Biofilm and Anti-Caries Potential of Arginine Combined with Calcium Glycerophosphate and Fluoride.

The aim of this work was to evaluate the antibiofilm and anticaries properties of the association of arginine (Arg) with calcium glycerophosphate (CaGP) and fluoride (F).... An active attachment, polymicrobial biofilm model obtained from saliva and bovine teeth discs were used. After the initial biofilm growth period, the enamel discs were transferred to culture medium. T... The association Arg+F+CaGP resulted in the lowest surface hardness loss in tooth enamel (-10.9±2.3%; p<0.05). Arg+F+CaGP exhibited highest values of subsurface mineral content (10.1±2.9 g... The Arg-F-Ca association demonstrated to be the most effective combination in protecting the loss of surface hardness and subsurface mineral content, in addition to controlling important virulence fac... Our findings provide evidence that the Arg-F-Ca association showed an additive effect, particularly concerning protection against enamel demineralization. The combination of these compounds may be a s...